Daegu, South Korea

Seong-Woon Yu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Daegu Gyeongbuk Institute of Science and Technology, Gliacelltech Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seong-Woon Yu: Innovator in Neuroinflammatory Disease Treatment

Introduction

Seong-Woon Yu is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of neuroinflammatory diseases through his innovative research and patent developments. His work focuses on the prevention and treatment of conditions such as Alzheimer's disease.

Latest Patents

Seong-Woon Yu holds a patent for a composition aimed at preventing or treating neuroinflammatory diseases, specifically one that includes didanosine. This composition is designed to inhibit the expression of neuroinflammatory cytokines, promote the degradation of amyloid beta, and improve cognitive function in animal models of Alzheimer's disease. The patent highlights the potential for this composition to be developed into drugs and quasi-drug materials.

Career Highlights

Throughout his career, Seong-Woon Yu has been associated with notable institutions such as the Daegu Gyeongbuk Institute of Science and Technology and Gliacelltech Inc. His work in these organizations has contributed to advancements in medical research and therapeutic solutions for neuroinflammatory conditions.

Collaborations

Seong-Woon Yu has collaborated with several professionals in his field, including Hyeri Nam and Younghwan Lee. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Seong-Woon Yu's contributions to the treatment of neuroinflammatory diseases through his patented compositions demonstrate his commitment to advancing medical science. His work not only addresses critical health issues but also paves the way for future innovations in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…